Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
16.45
-0.50 (-2.95%)
At close: Mar 9, 2026, 4:00 PM EDT
16.48
+0.03 (0.18%)
After-hours: Mar 9, 2026, 7:48 PM EDT

Tango Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Net Income
-101.59-130.3-101.74-108.18-58.24
Upgrade
Depreciation & Amortization
2.282.52.421.610.9
Upgrade
Loss (Gain) From Sale of Investments
-2.69-4.62-3.39--
Upgrade
Stock-Based Compensation
26.4328.919.0814.237.83
Upgrade
Other Operating Activities
3.883.773.631.751.32
Upgrade
Change in Accounts Receivable
--2--
Upgrade
Change in Accounts Payable
-0.83-1.18-1.711.11.23
Upgrade
Change in Unearned Revenue
-62.38-29.97-31.53-16.86-12.04
Upgrade
Change in Other Net Operating Assets
-3.99-0.59-6.73-2.73-0.54
Upgrade
Operating Cash Flow
-138.89-131.5-117.98-109.08-59.53
Upgrade
Capital Expenditures
-1.05-0.75-1.53-7.69-1.84
Upgrade
Investment in Securities
-39.8286.8842.9534.09-181.6
Upgrade
Investing Cash Flow
-40.8786.1341.4326.4-183.43
Upgrade
Issuance of Common Stock
222.5447.6682.651.621.06
Upgrade
Other Financing Activities
-0.04--0.24-0.01326.28
Upgrade
Financing Cash Flow
222.547.6682.411.62357.33
Upgrade
Net Cash Flow
42.752.295.85-81.07114.36
Upgrade
Free Cash Flow
-139.93-132.26-119.51-116.77-61.36
Upgrade
Free Cash Flow Margin
-224.31%-314.38%-327.18%-469.72%-165.66%
Upgrade
Free Cash Flow Per Share
-1.21-1.21-1.26-1.33-0.99
Upgrade
Levered Free Cash Flow
-60.86-67.27-61.82-48.74-34.02
Upgrade
Unlevered Free Cash Flow
-60.86-67.27-61.82-48.74-34.02
Upgrade
Change in Working Capital
-67.2-31.75-37.97-18.49-11.35
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.